Janssen Cilag S.a.s.

This study is testing if a personalized physical activity program can improve the day-to-day well-being of people with chronic lymphocytic leukemia (CLL) who are starting a medication called ibrutinib. It will involve 180 participants who will follow an exercise plan and track th…

This study aims to understand how well men with advanced prostate cancer stick to their prescribed medication, apalutamide, during the first year of treatment. Researchers will follow 270 patients in France to see who takes their pills as directed and explore the personal, social…